Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

January 14, 2014; 82 (2) WriteClick: Editor's Choice

In vivo identification of morphologic retinal abnormalities in neuromyelitis opticaAuthor Response

Francois-Xavier Borruat, Elias S. Sotirchos, Peter A. Calabresi
First published January 13, 2014, DOI: https://doi.org/10.1212/WNL.0000000000000003
Francois-Xavier Borruat
Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elias S. Sotirchos
Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter A. Calabresi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
In vivo identification of morphologic retinal abnormalities in neuromyelitis opticaAuthor Response
Francois-Xavier Borruat, Elias S. Sotirchos, Peter A. Calabresi
Neurology Jan 2014, 82 (2) 188-189; DOI: 10.1212/WNL.0000000000000003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
395

Share

  • Article
  • Info & Disclosures
Loading

Editors' Note: In reference to the article “In vivo identification of morphologic retinal abnormalities in neuromyelitis optica,” Dr. Borruat reports his own experience in diagnosing microcystic macular edema in patients with noninflammatory optic neuropathies, supporting the hypothesis of retrograde transsynaptic degeneration of inner retinal cells as etiology. Dr. Khoo espouses the benefits of Sniffin’ Sticks, an inexpensive, noninvasive test of olfactory dysfunction, in diagnosing idiopathic intracranial hypertension. Authors Kunte et al. explain the drawbacks of this approach. —Megan Alcauskas, MD, and Robert C. Griggs, MD

Sotirchos et al.1 used optical coherence tomography (OCT) and found microcystic macular edema (MME) in a cohort of patients with neuromyelitis optica (NMO). The authors considered the possible mechanisms leading to MME in NMO: a primary retinal inflammatory process, a retinopathy related to the high expression of aquaporin-4 in the inner retina, possible unrecognized episodes of uveitis, or a retrograde transsynaptic degeneration of inner retinal cells.

The authors recommended further OCT studies in other types of optic neuropathies to exclude or confirm a transsynaptic etiology of MME. During the past year, I diagnosed MME in 3 patients who presented with noninflammatory optic neuropathies: optic disc drusen, optic nerve compression from craniopharyngioma, and unilateral traumatic optic neuropathy. Similar to others,2,3 I believe that MME does not reflect a specific underlying inflammatory process but rather I consider it a marker of the severity of optic neuropathies. MME probably reflects a certain stage of retrograde transsynaptic degeneration,4,5 which can occur in optic neuropathies whatever the etiology.

Author Response

We thank Dr. Borruat for his comments on our study, in which we reported MME of the inner nuclear layer in 30% of eyes that had experienced NMO-associated optic neuritis.1 MME was associated with severe retinal axonal and neuronal loss and visual disability. We proposed that MME may develop as a consequence of either retrograde transsynaptic degeneration or a retinal inflammatory process. MME has also been reported in various noninflammatory optic neuropathies,2,6 and Dr. Borruat suggests this provides evidence supporting a transsynaptic etiology. We agree that this is a possibility, but this hypothesis does not satisfactorily explain why MME may fluctuate over time7,8 or why MME develops in only a subset of patients with severe optic neuropathies.1,5,6

We believe that severe optic atrophy is necessary but not sufficient to cause MME and that the possibility that secondary factors contribute to the development of MME must be considered. Secondary factors could include retinal inflammation1,7,8 with a humoral or cell-mediated immune response gaining access to the immune-privileged retina after breakdown of the blood–retinal barrier, a mechanical process such as vitreoretinal traction due to severe retinal atrophy resulting in schesis,6 or a genetic susceptibility to more extensive neurodegeneration.

References

  1. 1.↵
    1. Sotirchos ES,
    2. Saidha S,
    3. Byraiah G,
    4. et al
    . In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology 2013;80:1406–1414.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Abbegg M,
    2. Zinkernagel M,
    3. Wolf S
    . Microcystic macular degeneration from optic neuropathy. Brain 2012;135:e225.
    OpenUrlFREE Full Text
  3. 3.↵
    1. Balk LJ,
    2. Killestein J,
    3. Polman CH,
    4. Uitdehaag BMJ,
    5. Petzold A
    . Microcystic macular oedema confirmed, but not specific for multiple sclerosis. Brain 2012;135:e226.
    OpenUrlFREE Full Text
  4. 4.↵
    1. Van Buren JM
    . Trans-synaptic retrograde degeneration in the visual system of primates. J Neurol Neurosurg Psychiatry 1963;26:402–409.
    OpenUrlFREE Full Text
  5. 5.↵
    1. Gills JP,
    2. Wadsworth JAC
    . Retrograde transsynaptic degeneration of the inner nuclear layer of the retina. Invest Ophthalmol Vis Sci 1967;6:437–448.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Barboni P,
    2. Carelli V,
    3. Savini G,
    4. Carbonelli M,
    5. La Morgia C,
    6. Sadun AA
    . Microcystic macular degeneration from optic neuropathy: not inflammatory, not trans-synaptic degeneration. Brain 2013;136:e239.
    OpenUrlFREE Full Text
  7. 7.↵
    1. Gelfand JM,
    2. Nolan R,
    3. Schwartz DM,
    4. Graves J,
    5. Green AJ
    . Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 2012;135:1786–1793.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    1. Saidha S,
    2. Sotirchos ES,
    3. Ibrahim MA,
    4. et al
    . Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 2012;11:963–972.
    OpenUrlCrossRefPubMed
  • © 2014 American Academy of Neurology

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • References
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise